IRhythm Technologies Research and Development Expenses 2015-2025 | IRTC
IRhythm Technologies annual/quarterly research and development expenses history and growth rate from 2015 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
- IRhythm Technologies research and development expenses for the quarter ending March 31, 2025 were $0.022B, a 28.37% increase year-over-year.
- IRhythm Technologies research and development expenses for the twelve months ending March 31, 2025 were $0.109B, a 74.13% increase year-over-year.
- IRhythm Technologies annual research and development expenses for 2024 were $0.104B, a 72.35% increase from 2023.
- IRhythm Technologies annual research and development expenses for 2023 were $0.06B, a 29.25% increase from 2022.
- IRhythm Technologies annual research and development expenses for 2022 were $0.047B, a 20.53% increase from 2021.
| IRhythm Technologies Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $104 |
| 2023 | $60 |
| 2022 | $47 |
| 2021 | $39 |
| 2020 | $41 |
| 2019 | $37 |
| 2018 | $21 |
| 2017 | $13 |
| 2016 | $7 |
| 2015 | $6 |
| 2014 | $6 |
| IRhythm Technologies Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $22 |
| 2024-12-31 | $19 |
| 2024-09-30 | $48 |
| 2024-06-30 | $20 |
| 2024-03-31 | $17 |
| 2023-12-31 | $15 |
| 2023-09-30 | $16 |
| 2023-06-30 | $14 |
| 2023-03-31 | $15 |
| 2022-12-31 | $13 |
| 2022-09-30 | $11 |
| 2022-06-30 | $12 |
| 2022-03-31 | $11 |
| 2021-12-31 | $12 |
| 2021-09-30 | $9 |
| 2021-06-30 | $10 |
| 2021-03-31 | $9 |
| 2020-12-31 | $12 |
| 2020-09-30 | $9 |
| 2020-06-30 | $13 |
| 2020-03-31 | $8 |
| 2019-12-31 | $9 |
| 2019-09-30 | $13 |
| 2019-06-30 | $8 |
| 2019-03-31 | $7 |
| 2018-12-31 | $7 |
| 2018-09-30 | $5 |
| 2018-06-30 | $5 |
| 2018-03-31 | $4 |
| 2017-12-31 | $4 |
| 2017-09-30 | $4 |
| 2017-06-30 | $3 |
| 2017-03-31 | $3 |
| 2016-12-31 | $2 |
| 2016-09-30 | $2 |
| 2016-06-30 | $2 |
| 2016-03-31 | $2 |
| 2015-12-31 | |
| 2015-09-30 | $2 |
| 2015-06-30 | $0 |
| 2014-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.092B | $0.592B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.104B | 58.65 |
| Doximity (DOCS) | United States | $12.505B | 55.48 |
| Hims & Hers Health (HIMS) | United States | $11.626B | 96.18 |
| Tempus AI (TEM) | United States | $10.538B | 0.00 |
| Hinge Health (HNGE) | United States | $4.422B | 0.00 |
| Privia Health (PRVA) | United States | $2.526B | 187.09 |
| Inspire Medical Systems (INSP) | United States | $2.341B | 34.41 |
| Enovis (ENOV) | United States | $1.626B | 8.59 |
| Phreesia (PHR) | United States | $1.607B | 0.00 |
| 10x Genomics (TXG) | United States | $1.513B | 0.00 |
| Omnicell (OMCL) | United States | $1.416B | 27.28 |
| Schrodinger (SDGR) | United States | $1.410B | 0.00 |
| Azenta (AZTA) | United States | $1.331B | 58.06 |
| Clover Health Investments (CLOV) | United States | $1.109B | 0.00 |
| Evolent Health (EVH) | United States | $1.057B | 0.00 |
| Claritev (CTEV) | United States | $0.934B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.623B | 0.00 |
| Veradigm (MDRX) | United States | $0.514B | 0.00 |
| Standard BioTools (LAB) | United States | $0.496B | 0.00 |
| Talkspace (TALK) | United States | $0.418B | 125.00 |
| Zepp Health (ZEPP) | Netherlands | $0.360B | 0.00 |
| Carlsmed (CARL) | $0.337B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.335B | 0.00 |
| TruBridge (TBRG) | United States | $0.284B | 49.76 |
| Nyxoah SA (NYXH) | Belgium | $0.253B | 0.00 |
| Outset Medical (OM) | United States | $0.227B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.215B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.197B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.183B | 0.00 |
| CapsoVision (CV) | United States | $0.182B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.126B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.113B | 5.14 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.074B | 0.00 |
| Pulmonx (LUNG) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.033B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.020B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |